Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Takeda Pharmaceutical Co. Acquires Biologics Manufacturing Center In Brooklyn Park, Minnesota

01/06/2016
Takeda Pharmaceutical Co., the largest pharmaceutical company in Japan, acquired a biologics manufacturing facility in Brooklyn Park, Minnesota.

The company, which develops and markets medicines for treating cancer, gastrointestinal disorders, diabetes and other health problems, said the facility primarily will manufacture the prescription medication Entyvio (vedolizumab) and other biologic products.

Takeda officials said the facility at 9450 Winnetka Ave. N. will allow the company to maximize global efficiencies and further enhance the product’s supply chain flexibility.

“Takeda’s focus is providing patients access to quality therapies,” said Thomas Wozniewski, Global Manufacturing and Supply Officer at Takeda. “Acquiring the state-of-the-art Brooklyn Park facility and gaining access to a highly experienced and dedicated team is a very important strategic benefit for Takeda that reinforces and expands upon our global operations for Entyvio and future biologic products.”

“Minnesota is home to an innovative bioscience industry. We rank among the best nationally in the biosciences, generating more patents and jobs on a per capita basis than almost every other state,” said Lt. Governor Tina Smith. “Takeda Pharmaceutical Company will be a great addition to our state’s bioscience sector, and we are glad to welcome them to Minnesota.”

“We are grateful Takeda selected Brooklyn Park for their first U.S. manufacturing operation,” said Commissioner Katie Clark Sieben of the Minnesota Department of Employment and Economic Development (DEED). “This project will enable Takeda to expand its global footprint and further build the Twin Cities’ reputation as one of the country’s leading biotech hubs.”

Brooklyn Park Mayor Jeffrey Lunde said, “We are excited that Takeda will join the city’s growing headquarter and manufacturing corridor along Highway 610. Takeda fits into Brooklyn Park’s strategy to attract and retain high-quality jobs.”

Exclusive Research